Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Expression of Signaling Molecules in Progressive Multifocal Leukoencephalopathy.
Secondary B Cell Receptor Diversification Is Necessary for T Cell Mediated Neuro-Inflammation during Experimental Autoimmune Encephalomyelitis.
Albumin and Protein Oxidation are Predictors that Differentiate Relapsing-Remitting from Progressive Clinical Forms of Multiple Sclerosis.
T-bet is essential for Th1-mediated, but not Th17-mediated, CNS autoimmune disease.
T cell repertoire following autologous stem cell transplantation for multiple sclerosis.
A tetramethoxychalcone from Chloranthus henryi suppresses lipopolysaccharide-induced inflammatory responses in BV2 microglia.
Differential diagnosis and prognosis for longitudinally extensive myelitis in Buenos Aires, Argentina.
Long-term safety and efficacy of natalizumab in relapsing-remitting multiple sclerosis: impact on quality of life.
Quantitative evaluation of cerebral white matter in patients with multiple sclerosis using multicomponent T2 mapping.
Vitamin D is associated with degree of disability in patients with fully ambulatory relapsing-remitting multiple sclerosis.
Diffusion basis spectrum imaging detects and distinguishes coexisting subclinical inflammation, demyelination and axonal injury in experimental autoimmune encephalomyelitis mice.
Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis.
Multiparameter Flow Cytometric Assays to Quantify Effector and Regulatory T-Cell Function in Multiple Sclerosis.
Progress and Roadblocks Along the Pathway to Multiple Sclerosis Treatment.
Measuring Gray Matter and White Matter Damage in MS: Why This is Not Enough.
Eosinophilic CNS vasculitis can mimic demyelinating disease of the brain and spinal cord.
[Locomotive syndrome and Frailty. Vitamin D and Frailty].
The habenula and iron metabolism in cerebral mouse models of multiple sclerosis.
Unkind cytokines: current evidence for the potential role of cytokines in immune-mediated depression.
Celastrol Ameliorates EAE Induction by Suppressing Pathogenic T Cell Responses in the Peripheral and Central Nervous Systems.
USPIO-Enhanced MRI Neuroimaging: A Review.
Remote Neurodegeneration: Multiple Actors for One Play.
Use of altered informed consent in pragmatic clinical research.
Headaches in multiple sclerosis patients might imply an inflammatorial process.
Markers of JC virus infection in patients with multiple sclerosis under natalizumab therapy.
Pages
« first
‹ previous
…
588
589
590
591
592
593
594
595
596
…
next ›
last »